-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Covetrus, Inc. (NASDAQ:CVET) Receives $20.00 Consensus Target Price From Analysts
Covetrus, Inc. (NASDAQ:CVET) Receives $20.00 Consensus Target Price From Analysts
Covetrus, Inc. (NASDAQ:CVET – Get Rating) has been given an average rating of "Hold" by the seven ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $20.00.
CVET has been the topic of several analyst reports. Stifel Nicolaus lowered Covetrus from a "buy" rating to a "hold" rating and set a $22.00 price target on the stock. in a report on Monday, June 13th. TheStreet upgraded Covetrus from a "d+" rating to a "c-" rating in a report on Wednesday, September 28th.
Get Covetrus alerts:Insider Activity at Covetrus
In related news, CEO Benjamin Wolin sold 5,292 shares of the business's stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $20.80, for a total value of $110,073.60. Following the sale, the chief executive officer now directly owns 199,780 shares in the company, valued at approximately $4,155,424. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.40% of the stock is owned by insiders.
Hedge Funds Weigh In On Covetrus
Institutional investors have recently bought and sold shares of the company. Assetmark Inc. grew its position in Covetrus by 385.7% in the 2nd quarter. Assetmark Inc. now owns 1,700 shares of the company's stock valued at $35,000 after acquiring an additional 1,350 shares in the last quarter. Point72 Hong Kong Ltd acquired a new position in shares of Covetrus during the first quarter worth about $43,000. US Bancorp DE grew its position in shares of Covetrus by 77.6% during the second quarter. US Bancorp DE now owns 4,708 shares of the company's stock worth $98,000 after buying an additional 2,057 shares in the last quarter. Aaron Wealth Advisors LLC acquired a new position in shares of Covetrus during the first quarter worth about $339,000. Finally, Crossmark Global Holdings Inc. acquired a new position in shares of Covetrus during the first quarter worth about $170,000. 92.20% of the stock is owned by institutional investors and hedge funds.Covetrus Trading Down 0.1 %
Shares of CVET opened at $20.88 on Friday. Covetrus has a 52-week low of $13.39 and a 52-week high of $21.20. The company has a quick ratio of 1.08, a current ratio of 1.88 and a debt-to-equity ratio of 0.65. The firm's fifty day moving average is $20.84 and its two-hundred day moving average is $19.15. The stock has a market cap of $2.93 billion, a PE ratio of -208.80 and a beta of 1.63.
Covetrus (NASDAQ:CVET – Get Rating) last posted its quarterly earnings results on Thursday, August 4th. The company reported $0.20 EPS for the quarter, hitting the consensus estimate of $0.20. Covetrus had a positive return on equity of 6.83% and a negative net margin of 0.28%. The business had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.23 billion. Research analysts forecast that Covetrus will post 0.84 earnings per share for the current fiscal year.
Covetrus Company Profile
(Get Rating)
Covetrus, Inc, together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers.
See Also
- Get a free copy of the StockNews.com research report on Covetrus (CVET)
- Magna International is Your Auto and EV One-Stop Shop Stock
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Let Paychex Stock Work Hard For You
Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.
Covetrus, Inc. (NASDAQ:CVET – Get Rating) has been given an average rating of "Hold" by the seven ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $20.00.
據Marketbeat.com報道，納斯達克(股票代碼：CVET-GET Rating)目前涵蓋該股的七家評級公司給予該公司的平均評級為“持有”。一位股票研究分析師對該股的評級為賣出，五位分析師對該公司的評級為持有。在過去一年對該股進行評級的經紀商中，12個月的平均目標價為20.00美元。
CVET has been the topic of several analyst reports. Stifel Nicolaus lowered Covetrus from a "buy" rating to a "hold" rating and set a $22.00 price target on the stock. in a report on Monday, June 13th. TheStreet upgraded Covetrus from a "d+" rating to a "c-" rating in a report on Wednesday, September 28th.
CVeT一直是幾份分析師報告的主題。Stifel Nicolaus將Covetrus的評級從買入下調至持有，併為該股設定了22.00美元的目標價。在6月13日星期一的一份報告中。華爾街在9月28日週三的一份報告中將Covetrus的評級從“d+”上調至“c-”。
Insider Activity at Covetrus
Covetrus的內幕活動
In related news, CEO Benjamin Wolin sold 5,292 shares of the business's stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $20.80, for a total value of $110,073.60. Following the sale, the chief executive officer now directly owns 199,780 shares in the company, valued at approximately $4,155,424. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.40% of the stock is owned by insiders.
在相關新聞中，首席執行官本傑明·沃林在日期為8月9日(星期二)的交易中出售了5,292股該公司股票。這些股票的平均價格為20.80美元，總價值為110,073.60美元。出售後，首席執行官現在直接擁有該公司199,780股，價值約4,155,424美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的，該文件可以通過這個環節。該公司0.40%的股份由內部人士持有。
Hedge Funds Weigh In On Covetrus
對衝基金參與了Covetrus的交易
Covetrus Trading Down 0.1 %
椰子交易下跌0.1%
Shares of CVET opened at $20.88 on Friday. Covetrus has a 52-week low of $13.39 and a 52-week high of $21.20. The company has a quick ratio of 1.08, a current ratio of 1.88 and a debt-to-equity ratio of 0.65. The firm's fifty day moving average is $20.84 and its two-hundred day moving average is $19.15. The stock has a market cap of $2.93 billion, a PE ratio of -208.80 and a beta of 1.63.
CVeT的股價上週五開盤報20.88美元。Covetrus的52周低點為13.39美元，52周高位為21.20美元。該公司的速動比率為1.08，流動比率為1.88，債務權益比率為0.65。該公司的50日移動均線切入位為20.84美元，200日移動均線切入位為19.15美元。該股市值29.3億美元，市盈率為-208.80，貝塔係數為1.63.
Covetrus (NASDAQ:CVET – Get Rating) last posted its quarterly earnings results on Thursday, August 4th. The company reported $0.20 EPS for the quarter, hitting the consensus estimate of $0.20. Covetrus had a positive return on equity of 6.83% and a negative net margin of 0.28%. The business had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.23 billion. Research analysts forecast that Covetrus will post 0.84 earnings per share for the current fiscal year.
納斯達克(股票代碼：CVET-GET Rating)最近一次公佈季度收益是在8月4日星期四。該公司公佈本季度每股收益為0.20美元，超過了普遍預期的0.20美元。Covetrus的股本回報率為正6.83%，淨利潤率為負0.28%。該業務本季度營收為12.2億美元，而分析師預期為12.3億美元。研究分析師預測，Covetrus本財年將公佈每股收益0.84美元。
Covetrus Company Profile
Covetrus公司簡介
(Get Rating)
(獲取評級)
Covetrus, Inc, together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers.
Covetrus，Inc.及其子公司是一家動物保健技術和服務公司。它從事向批發和零售客户銷售動物健康消耗品，包括專利和Covetrus品牌產品、小型設備、實驗室產品、大型設備、設備維修服務、品牌和仿製藥、疫苗、外科產品、診斷測試、感染控制產品、寄生蟲藥以及維生素和補充劑。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Covetrus (CVET)
- Magna International is Your Auto and EV One-Stop Shop Stock
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Let Paychex Stock Work Hard For You
- 免費獲取StockNews.com關於Covetrus的研究報告(CVeT)
- 麥格納國際是您的汽車和電動汽車一站式庫存
- 電動汽車電池製造商Freyr將在全球大舉擴張
- MarketBeat：回顧一週9/26-9/30
- 這是買入美光科技的難忘時刻
- 讓Paychex股票為您努力工作
Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.
接受《椰子日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Covetrus和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧